---
title: "Eli Lilly & Co (LLY) Gets a Buy from Citi"
description: "Meacham covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Amgen, and Vertex Pharmaceuticals. According to TipRanks, Meacham has an average return of 4.2% and a 55.14% success ra"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260882061.md"
published_at: "2025-10-13T10:55:53.000Z"
---

# Eli Lilly & Co (LLY) Gets a Buy from Citi

> Meacham covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Amgen, and Vertex Pharmaceuticals. According to TipRanks, Meacham has an average return of 4.2% and a 55.14% success rate on recommended stocks. In addition to Citi, Eli Lilly & Co also received a Buy from Wells Fargo’s Mohit Bansal in a report issued on October 10. However, on October 1, HSBC maintained a Hold rating on Eli Lilly & Co (NYSE: LLY).

Meacham covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Amgen, and Vertex Pharmaceuticals. According to TipRanks, Meacham has an average return of 4.2% and a 55.14% success rate on recommended stocks.

In addition to Citi, Eli Lilly & Co also received a Buy from Wells Fargo’s Mohit Bansal in a report issued on October 10. However, on October 1, HSBC maintained a Hold rating on Eli Lilly & Co (NYSE: LLY).

### Related Stocks

- [LLY.US - Eli Lilly](https://longbridge.com/en/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 禮來公司 $LLY 的股票被 Assetmark Inc. 收購 | Assetmark Inc. 在第三季度將其在禮來的持股增加了 6.0%，目前持有 55,360 股，價值為 4224 萬美元。其他機構投資者也增持了股份，82.53% 的股票由對沖基金持有。禮來的股票開盤價為 1,040.12 美元，市值 | [Link](https://longbridge.com/en/news/275971336.md) |
| 禮來公司（Eli Lilly）的股票（LLY）因其計劃在印度投資 10 億美元而上漲 | 禮來的股票（LLY）在宣佈向印度投資 10 億美元以增強其合同製造業務後上漲了約 1%。這項投資旨在將印度定位為國際市場，特別是亞洲的製造中心。禮來計劃在印度推出新產品，包括其阿爾茨海默病藥物 Donanemab。自 2020 年以來，該公 | [Link](https://longbridge.com/en/news/276152620.md) |
| 吉姆·克萊默討論禮來公司（Eli Lilly）及其減肥藥物 | 吉姆·克萊默最近討論了禮來公司（NYSE:LLY），該公司的股票在過去一年中上漲了 23.5%，儘管今年迄今為止下跌超過 1%。在克萊默提到的 17 只股票中，禮來公司被特別強調，顯示出其在當前市場討論中的重要性 | [Link](https://longbridge.com/en/news/276258256.md) |
| Balentine LLC 購買了禮來公司 $LLY 的股票 | Balentine LLC 在第三季度將其在禮來公司（NYSE: LLY）的持股增加了 150.1%，目前擁有 4,042 股，價值 308 萬美元。其他投資者，包括 Laurel Wealth Advisors 和 Norges Bank | [Link](https://longbridge.com/en/news/276105002.md) |
| 禮來公司（LLY）建立了價值 15 億美元的減肥藥庫存 | 禮來（LLY）已準備好 15 億美元的庫存，以迎接其新減肥藥 Orforglipron 預計在四月獲得 FDA 批准。該公司計劃在今夏推出該藥，並進行大規模的營銷活動，以與諾和諾德的 Wegovy 競爭。分析師對禮來的股票給予了一致的強烈買 | [Link](https://longbridge.com/en/news/276070062.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.